Improved survival with ipilimumab in patients with metastatic melanoma.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Improved survival with ipilimumab in patients with metastatic melanoma.
- Published In:
- The New England journal of medicine, 363(8), 711-23 (2010)
- Authors:
- Hodi, F Stephen, O'Day, Steven J, McDermott, David F, Weber, Robert W, Sosman, Jeffrey A, Haanen, John B, Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C, Akerley, Wallace, van den Eertwegh, Alfons J M, Lutzky, Jose, Lorigan, Paul, Vaubel, Julia M, Linette, Gerald P, Hogg, David, Ottensmeier, Christian H, Lebbé, Celeste, Peschel, Christian, Quirt, Ian, Clark, Joseph I, Wolchok, Jedd D, Weber, Jeffrey S, Tian, Jason, Yellin, Michael J, Nichol, Geoffrey M, Hoos, Axel, Urba, Walter J
- Database ID:
- RPEP-01627
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01627APA
Hodi, F Stephen; O'Day, Steven J; McDermott, David F; Weber, Robert W; Sosman, Jeffrey A; Haanen, John B; Gonzalez, Rene; Robert, Caroline; Schadendorf, Dirk; Hassel, Jessica C; Akerley, Wallace; van den Eertwegh, Alfons J M; Lutzky, Jose; Lorigan, Paul; Vaubel, Julia M; Linette, Gerald P; Hogg, David; Ottensmeier, Christian H; Lebbé, Celeste; Peschel, Christian; Quirt, Ian; Clark, Joseph I; Wolchok, Jedd D; Weber, Jeffrey S; Tian, Jason; Yellin, Michael J; Nichol, Geoffrey M; Hoos, Axel; Urba, Walter J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma.. The New England journal of medicine, 363(8), 711-23. https://doi.org/10.1056/NEJMoa1003466
MLA
Hodi, F Stephen, et al. "Improved survival with ipilimumab in patients with metastatic melanoma.." The New England journal of medicine, 2010. https://doi.org/10.1056/NEJMoa1003466
RethinkPeptides
RethinkPeptides Research Database. "Improved survival with ipilimumab in patients with metastati..." RPEP-01627. Retrieved from https://rethinkpeptides.com/research/hodi-2010-improved-survival-with-ipilimumab
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.